共 50 条
- [1] Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab: Results of the expansion part of a phase I study in patients with metastatic colorectal cancerJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)Bordonaro, Roberto论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyCalvo, Aitana论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyAuriemma, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyHollebecque, Antoine论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyRubovszky, Gabor论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalySaunders, Mark P.论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyPapai, Zsuzsanna论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyPrager, Gerald W.论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyStein, Alexander论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyAndre, Thierry论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyArgiles, Guillem论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyCubillo, Antonio论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyDahan, Laetitia论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyEdeline, Julien论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyLeger, Catherine论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyAmellal, Nadia论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyCattan, Valerie论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, ItalyTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Natl Specialist Hosp Garibaldi, Med Oncol, Catania, Italy
- [2] Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancerEUROPEAN JOURNAL OF CANCER, 2019, 112 : 12 - 19Argiles, Guillem论文数: 0 引用数: 0 h-index: 0机构: Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, Spain Univ Autonoma Barcelona, Inst Oncol VHIO, Barcelona, Spain Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainAndre, Thierry论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, 184 Rue Faubourg St Antoine, Paris, France Hop St Antoine, Serv Oncol Med, 184 Rue Faubourg St Antoine, Paris, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainHollebecque, Antoine论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, DITEP, Drug Dev Dept, Canc Campus, Villejuif, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainCalvo, Aitana论文数: 0 引用数: 0 h-index: 0机构: Gregorio Maranon Univ Gen Hosp, Madrid, Spain Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainDahan, Laetitia论文数: 0 引用数: 0 h-index: 0机构: Aix Marseille Univ, AP HM, Ctr Essais Precoces Cancerol Marseille CLIP2, Marseille, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainCervantes, Andres论文数: 0 引用数: 0 h-index: 0机构: Univ Valencia, CIBERONC, Dept Med Oncol, Biomed Res Inst INCLIVA, Valencia, Spain Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainLeger, Catherine论文数: 0 引用数: 0 h-index: 0机构: Inst Rech Int Servier, Suresnes, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainAmellal, Nadia论文数: 0 引用数: 0 h-index: 0机构: Inst Rech Int Servier, Suresnes, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainFougeray, Ronan论文数: 0 引用数: 0 h-index: 0机构: Inst Rech Int Servier, Suresnes, France Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, SpainTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, Spain Univ Autonoma Barcelona, Inst Oncol VHIO, Barcelona, Spain Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Barcelona, Spain
- [3] A phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in metastatic colorectal cancer.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Hollebecque, Antoine论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceArgiles, Guillem论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceAndre, Thierry论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceCervantes, Andres论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceLeger, Catherine论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceValette, Aude论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceAmellal, Nadia论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceFougeray, Ronan论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, FranceTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
- [4] A phase I expansion study of trifluridine and tipiracil (FTD/TPI) in combination with irinotecan (IRI) and bevacizumab (BEV) in patients with metastatic colorectal cancer (mCRC).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Varghese, Anna M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USACardin, Dana Backlund论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAHersch, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USABenson, Al Bowen论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAHochster, Howard S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAWinkler, Robert E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USABenedetti, Fabio论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAHamada, Kensuke论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USABerlin, Jordan论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASaltz, Leonard B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
- [5] A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN studyINVESTIGATIONAL NEW DRUGS, 2020, 38 (01) : 111 - 119Suenaga, Mitsukuni论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanWakatsuki, Takeru论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanMashima, Tetsuo论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanOgura, Mariko论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanIchimura, Takashi论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanShinozaki, Eiji论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanNakayama, Izuma论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanOsumi, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanOta, Yumiko论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanTakahari, Daisuke论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanChin, Keisho论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanSeimiya, Hiroyuki论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, JapanYamaguchi, Kensei论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan
- [6] Safety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC)ANNALS OF ONCOLOGY, 2018, 29Calvo Ferrandiz, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainDahan, L.论文数: 0 引用数: 0 h-index: 0机构: CHU La Timone Enfants, Serv HGE & Oncol, Marseille, France Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainHollebecque, A.论文数: 0 引用数: 0 h-index: 0机构: Inst Gustave Roussy, DITEP, Drug Dev Dept, Villejuif, France Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainPrager, G.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Comprehens Canc Ctr Vienna, Vienna, Austria Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainAndre, T.论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, Serv Oncol Med, Paris, France Hop St Antoine, Paris, France Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainArgiles Martinez, G.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Inst Oncol, Barcelona, Spain Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainBordonaro, R.论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Garibaldi, SC Oncol Med ARNAS, Catania, Italy Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainStein, A.论文数: 0 引用数: 0 h-index: 0机构: UKE Univ Klinikum Hamburg Eppendorf KMTZ, KMT Sekt Pneumol, Hamatol, Onkol, Hamburg, Germany Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainTortora, G.论文数: 0 引用数: 0 h-index: 0机构: AOUI, UOC Oncol, Policlin GB Rossi, Verona, Italy Univ Verona, Verona, Italy Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainLeger, C.论文数: 0 引用数: 0 h-index: 0机构: Servier France, Oncol Med Div, Suresnes, France Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainAmellal, N.论文数: 0 引用数: 0 h-index: 0机构: Servier, Oncol Med Div, Suresnes, France Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, SpainTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
- [7] A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN studyInvestigational New Drugs, 2020, 38 : 111 - 119Mitsukuni Suenaga论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyTakeru Wakatsuki论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyTetsuo Mashima论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyMariko Ogura论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyTakashi Ichimura论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyEiji Shinozaki论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyIzuma Nakayama论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyHiroki Osumi论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyYumiko Ota论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyDaisuke Takahari论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyKeisho Chin论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyHiroyuki Seimiya论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological ChemotherapyKensei Yamaguchi论文数: 0 引用数: 0 h-index: 0机构: Cancer Institute Hospital,Department of Gastroenterological Chemotherapy
- [8] A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN studyANNALS OF ONCOLOGY, 2018, 29 : 158 - 158Suenaga, M.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanWakatsuki, T.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanOgura, M.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanIchimura, T.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanShinozaki, E.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanNakayama, I.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanOsumi, H.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanOta, Y.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanChin, K.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanMashima, T.论文数: 0 引用数: 0 h-index: 0机构: Canc Chemotherapy Ctr JFCR, Mol Biotherapy, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanSeimiya, H.论文数: 0 引用数: 0 h-index: 0机构: Canc Chemotherapy Ctr JFCR, Mol Biotherapy, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanTakahari, D.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, JapanYamaguchi, K.论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan
- [9] A phase II study of trifluridine/tipiracil, irinotecan, and bevacizumab in pretreated metastatic colorectal cancer (TABAsCO)JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)Gupta, Medhavi论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAFountzilas, Christos论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAVijayvergia, Namrata论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAAttwood, Kristopher论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAHochster, Howard S.论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAMukherjee, Sarbajit论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USAIyer, Renuka V.论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USABoland, Patrick Mckay论文数: 0 引用数: 0 h-index: 0机构: Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USA
- [10] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal CancerNEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667Prager, Gerald W.论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, Austria Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaTaieb, Julien论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Cite, Dept Gastroenterol & Digest Oncol, Georges Pompidou European Hosp, SIRIC,Canc Res Personalized Med, Paris, France Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaFakih, Marwan论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Duarte, CA USA Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaCiardiello, Fortunato论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Dept Digest Oncol, Leuven, Belgium Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaElez, Elena论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Hosp Campus, Dept Med Oncol, Barcelona, Spain Int Oncol Bureau Quiron, Inst Oncol, Barcelona, Spain Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaCruz, Felipe M.论文数: 0 引用数: 0 h-index: 0机构: Nucleo Pesquisa & Ensino Rede Sao Camilo, Sao Paulo, Brazil Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaWyrwicz, Lucjan论文数: 0 引用数: 0 h-index: 0机构: Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiotherapy & Oncol, Warsaw, Poland Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaStroyakovskiy, Daniil论文数: 0 引用数: 0 h-index: 0机构: Moscow City Oncol Hosp, Moscow Healthcare Dept, Moscow, Russia Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaPapai, Zsuzsanna论文数: 0 引用数: 0 h-index: 0机构: Hungarian Def Forces Med Ctr, Dept Oncol, Budapest, Hungary Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaPoureau, Pierre-Guillaume论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Oncol, Brest, France Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaLiposits, Gabor论文数: 0 引用数: 0 h-index: 0机构: Reg Hosp West Jutland, Dept Oncol, Herning, Denmark Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, Austria论文数: 引用数: h-index:机构:Bondarenko, Igor论文数: 0 引用数: 0 h-index: 0机构: Dnipro State Med Univ, Dnipro, Ukraine Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaModest, Dominik P.论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Dept Med Hematol Oncol & Canc Immunol, Berlin, Germany Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaBenhadji, Karim A.论文数: 0 引用数: 0 h-index: 0机构: Taiho Oncol, Princeton, NJ USA Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaAmellal, Nadia论文数: 0 引用数: 0 h-index: 0机构: Servier, Suresnes, France Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaLeger, Catherine论文数: 0 引用数: 0 h-index: 0机构: Servier, Suresnes, France Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaVidot, Loick论文数: 0 引用数: 0 h-index: 0机构: Servier, Suresnes, France Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, AustriaTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Hosp Campus, Dept Med Oncol, Barcelona, Spain Int Oncol Bureau Quiron, Inst Oncol, Barcelona, Spain Med Univ Vienna, Dept Med 1, Ctr Comprehens Canc, Vienna, Austria